Sensitive ultra-fast liquid chromatography method for rosmarinic acid determination in Wistar rat’s plasma and brain by Fachel, Flávia Nathiely Silveira et al.
Drug Analytical Research 
ISSN: 2527-2616                Drug Anal Res, 2019; v. 3, n. 02, 2-6 
 
Sensitive ultra-fast liquid chromatography method for rosmarinic acid determination 
in Wistar rat’s plasma and brain  
 
Flávia Nathiely Silveira Fachel*a, Luana Roberta Michelsa, Juliana Hofstätter Azambujab, Valquíria Linck Bassania, Letícia 
Scherer Koestera, Amelia Teresinha Henriquesa, Elizandra Braganholb, Helder Ferreira Teixeiraa 
a Programa de Pós‐Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do 
Sul (UFRGS), Porto Alegre, RS, Brazil; b Programa de Pós‐Graduação em Biociências, Universidade Federal de Ciências da 
Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil. 
 
*Corresponding author: flavia_fachel@hotmail.com 
 
 
Rosmarinic acid (RA) is a polyphenolic compound recently associated to a neuroprotective potential. Nevertheless, besides the RA 
poor bioavailability and availability in the central nervous system (CNS) some alternatives to RA delivery, protection, and release 
been investigated. Recently, our research group optimized chitosan-coated nanoemulsions for RA nasal administration and 
demonstrated the glioprotective effect against LPS-induced damage in astrocytes. In this context, this study aimed to validate a fast 
and simplified UFLC method previously reported by our research group for RA determination in Wistar rat’s plasma and brain, to 
be employed in further in vivo studies, since the nasal route for RA are not completely understood. The method was validated in 
terms of specificity, linearity, matrix effect, stability, precision, accuracy and extraction recovery for rat plasma and brain, according 
to the official guidelines. The method was sensitive, linear (0.1 – 10.0 µg.mL−1), precise and accurate, and showed RA recovery 
higher than 85% in plasma and brain. Overall results demonstrated that method was successfully validated for determination of RA 
in rat plasma and brain matrices with high sensibility and with high recovery using simple extraction processes. 
Keywords: Rosmarinic acid; UFLC method; plasma; brain; Wistar rats. 
 
 
Introduction  
 
Rosmarinic acid (RA) is a polyphenolic compound (Fig.1), an 
ester of caffeic acid and 3,4-dihydroxyphenyllactic acid. It 
has numerous biological activities, including a current well-
documented anti-inflammatory and antioxidant activities 
recently associated to a neuroprotective potential [1–6]. 
Nevertheless, besides the RA poor bioavailability and 
availability in the central nervous system (CNS), in view of 
its limited ability to cross the blood-brain barrier (BBB),  
some alternatives to RA delivery, protection, and release been 
investigated intended to be used as a new neuroprotective 
therapy [1,7,8].  
Nasal route has been emerged as an alternative strategy for 
drugs delivery directly to CNS, owing to its ability to by 
passing BBB, an important obstacle for the delivery of 
therapeutic agents [9]. In this way, our research group 
optimized chitosan-coated nanoemulsions for RA nasal 
administration, since we have recognised that the association 
of lipid nanotechnology-based delivery systems with 
mucoadhesive polymers have been a promising approach to 
improve RA penetration through biological barriers and its 
residence time in nasal cavity [10]. Additionally, we have 
recently demonstrated the glioprotective effect against LPS-
induced damage in rat astrocyte primary cultures [11].  
However, further in vivo studies to evaluate this promising 
neuroprotective approach are still crucial. In this context, this 
study aimed to validate a fast and simplified ultra-fast liquid 
chromatography (UFLC) method previously developed by 
our research group [12] for RA determination in Wistar rat’s 
plasma and brain, to be employed in further in vivo studies, 
since the nasal route for RA are not completely understood. 
 
 
 
 
Figure 1. Rosmarinic acid (RA) chemical structure.  
 
Experimental 
Chemicals and reagents 
RA reference standard with over 98% purity was acquired 
from Carbosynth Ltd. (Berkshire, GB). Acetonitrile, 
methanol, and trifluoracetic acid liquid chromatographic 
grade were purchased from Tedia (Rio de Janeiro, BR). 
Reverse osmosis using a Milli-Q apparatus (Millipore, 
Billerica, US) was employed to obtain ultra-pure water.  
 Instrumentation and chromatographic conditions 
UFLC Shimadzu Prominence series system equipped with an 
automatic injector, a photodiode array (PDA) detector and an 
LC solutions software (Kyoto, Japan) was employed for RA 
analyses. Kinetex C18 column (100 x 2.1 mm i.d.; particle 
size, 2.6 µm; Phenomenex, USA) guarded by a pre-column 
filter in-line Ultra (Phenomenex, USA) was employed for 
chromatographic separation at 55 ºC, flow rate of 0.55 
mL.min-1, injection volume of  3 µL and detection 
wavelength of  330 nm. An isocratic eluent composed of 
water and acetonitrile (83:17, v/v), acidified with 0.1% 
trifluoracetic acid (v/v), was employed up to 3.5 min [12].  
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Standard and matrices solutions preparation 
RA standard 
A stock solution of RA (1.0 mg.mL-1) was prepared in 
methanol. The stock solution was then diluted in 
water/acetonitrile mixture (80:20; v:v) to obtain a series of 
working standard solutions. The stock and standard solution 
were maintained in darkness at 4 ± 2 °C. 
Rat plasma and brain matrices 
Plasma matrix from Wistar rats was prepared by proteins 
precipitation using trichloroacetic acid 5% (w/v). Plasma 
homogenates were centrifuged (1,000 g, 10 min), the 
supernatants were collected, diluted 1:1 in water:acetonitrile 
mixture (80:20; v:v) and filtered through a 0.22 μm nylon 
syringes filter.  
Brain matrix from Wistar rats was obtained by 
homogenization of tissue with methanol (3 mL per g of tissue) 
and further sonication in ultrasonic bath for 30 min. Brain 
homogenates were centrifuged (1,000 g, 10 min), the 
supernatants were collected and filtered through a 0.22 μm 
nylon syringes filter.  
 
Method validation 
The UFLC method previously reported by our research group 
[12] was validated in terms of specificity, linearity, matrix 
effect, stability, precision, accuracy and extraction recovery 
for rat plasma and brain, according to the official guidelines 
[13–15].  
System suitability 
Before method validation, system suitability parameters 
(peak area, retention time, theoretical plates and tailing factor 
of RA) were achieved to verify the appropriateness of the 
chromatographic system for the proposed analysis [16]. 
Specificity  
The specificity was obtained by comparing chromatograms 
(peak purity and retention time) of pure RA standard solution 
with chromatograms of matrices (plasma and brain) spiked 
with RA at the concentration of 10 µg.mL−1 and matrices 
solutions (blank samples). 
Linearity, matrix effect and stability 
The linearity was determined by regression analysis using the 
least square method. Three standard curves were obtained in 
three consecutive days by plotting the measured peak area 
versus the RA concentration in standard and matrices (0.1, 
2.0, 4.0, 6.0, 8.0, and 10.0 µg.mL−1), by six replicates per 
concentration. Analysis of variance (ANOVA) were used to 
analyse the results using a significance level of α=0.05. 
The matrix effect of plasma and brain was evaluated by the 
comparison of RA-spiked matrices standard curve slopes 
obtained during the linearity assay with pure RA standard 
curve slope.  
The stability of RA standard and RA-spiked matrices was 
assessed by performing the analysis of peak area and 
detecting any alteration in the chromatographic pattern of the 
stored samples (room temperature = 25 ± 1 ºC) for 24 h 
compared with a freshly prepared sample, intending to 
overestimate the time expended during routine analysis.  
Precision and accuracy 
The precision was evaluated as both intra-day precision 
(repeatability) and inter-day precision (intermediate 
precision) expressed as the relative standard deviations (% 
RSD) at four RA different levels (0.1, 2.0, 6.0, 10.0 µg.mL−1), 
in six replicates at each level. 
The accuracy was evaluated by adding known amounts of the 
RA standard at four different levels (0.1, 2.0, 6.0, 10.0 
µg.mL−1), in six replicates at each level, and was determined 
as follows: AC % = (mean experimental concentration x 100/ 
mean theoretical concentration). 
Extraction recovery  
The RA extraction recovery was evaluated from Wistar rats 
plasma and brain spiked with known amounts of RA standard 
leading to a theoretical concentration of 0.1, 2.0, 6.0 and 10.0 
µg.mL−1. To plasma matrices trichloroacetic acid 5% (w/v) in 
proportion 1:1 (v:v) was added. Then, plasma homogenates 
were centrifugated (1,000 g, 10 min), the supernatants were 
collected and diluted in water/acetonitrile mixture (80:20; 
v:v). Brain tissues (previously washed with saline) were 
homogenized with 2 mL of methanol per g of tissue in an 
IKA® Ultra-Turrax T8 mixer (IKA Works Inc., Wilmington, 
US).  All matrices were filtered through a 0.22 μm nylon 
syringes filter and analyzed by UFLC method. The recovery 
was expressed as percentage, assessed by comparing the 
theoretical final concentration based on the spiked amount 
and the experimental result attained after extraction 
procedure. 
Ethical committee approval  
All animal procedures were conducted with prior approval 
from the ethical approval of Federal University of Health 
Sciences of Porto Alegre, Brazil (Protocol 220/2017) and in 
accordance with the Brazilian Guidelines for the Care and 
Use of Animals in Scientific Research Activities (DBCA) and 
the National Council of Control of Animal Experimentation 
(CONCEA). 
Results and Discussion 
 Method validation  
Different methodologies for RA quantification through liquid 
chromatography techniques has been reported in literature 
[17–29]. Nevertheless, most of these methodologies focus on 
RA analysis in plant extracts and involves time consuming/ 
gradient eluent systems. In this context, recently our research 
group develop a fast and simplified UFLC method [12] for 
RA analysis based on its capability to promote ultra-high-
speed analysis with shorter runtimes in comparison with 
previous literature, high precision and sensibility. 
The UFLC method was the first report for RA determination 
in nanoemulsions, and porcine skin and nasal mucosa 
retention/permeation assay. In the literature, only few studies 
around validation of bioanalytical methods for biological 
matrices were found for RA determination, although, none of 
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them included rat plasma and brain under the same 
experimental conditions [22,30–32]. 
Regarding the system suitability, overall results demonstrated 
that the UFLC method is suitable for RA analysis in rat 
plasma and brain [16]. The parameters values and their 
relative standard deviation (RSD, %) were: retention time of 
2.63 (0.05) min, theoretical plates of 5446.82 (0.08), and 
tailing factor of 1.25 (0.06). 
The method was specific for RA determination in rat plasma 
and brain matrices, once the RA peak purity was 
demonstrated in RA spiked-matrices and no co-eluting 
substances in the same RA retention time were detected in 
matrices (Fig. 2).  
 
 
Figure 2. RA chromatographic profile standard at 10 µg.mL-1 and 
specificity in blank samples of rat plasma and brain. RA: rosmarinic 
acid. 
 
As presented in Table 1, the method was linear for RA 
determination in rat plasma and brain matrices in range of   
0.1–1.0 µg.mL-1 according with correlation coefficients. 
Linear regression and the absence of linearity deviation were 
also demonstrated by ANOVA evaluation of regression 
significance and confidence interval on the intercepts. LOQ 
was fixed at 0.1 µg.mL−1 as it was the lowest concentration 
of RA that could be quantified with acceptable precision and 
accuracy. 
The results for rat plasma and brain matrices effects (Table 1) 
were lower than 2.7% and indicates a low matrix effect in RA 
analysis [12,33]. The matrix effect is a very important 
parameter in biological samples to ensure the RA correct 
quantification in presence of matrices [34,35].  
The results obtained for intra and inter-day precision, 
accuracy and stability in standard and rat plasma and brain 
matrices are shown in Table 2.  Four different concentrations 
of RA standard and spiked-matrices were evaluated: 0.1 
µg.mL−1 (LOQ), 2.0 µg.mL−1 (lowest concentration), 6.0 
µg.mL−1 (medium concentration), and 10.0 µg.mL−1 (highest 
concentration) for each sample. The method was considered 
precise and accurate for RA determination in rat plasma and 
brain matrices according to official guidelines [13–15]. The 
intra-day and inter-day precision results demonstrated a 
relative standard deviation (RSD, %) lower than 5%. The 
accuracy ranged within 104.69 to 110.99% range. The 
stability data also demonstrated that the RA concentration 
remained constant in matrices even after 24 h of storage 
(room temperature = 25 ± 1 ºC). 
 
 
 
 
 
Table 1. Linearity and summary of the output of the ANOVA of RA 
standard, rat plasma brain matrices. 
  RA standard 
Rat plasma 
matrix 
Rat brain 
matrix 
 Range 
 (µg.mL-1) 
0.1 – 10.0 0.1 – 10.0 0.1 – 10.0 
 
Regression 
equation 
y = 8592x – 
183.18 
y = 8777.8x – 
238.3 
y = 8829.7x 
– 40.559 
 R  0.9996 0.9994 0.9996 
 
Matrix effect 
(%) 
- 2.12 2.69 
R
eg
re
ss
io
n
 
Significance F 2.239E-94a 6.376E-90 a 1.851E-97 a 
In
te
rc
ep
t p-value 0.32600
b 0.2865 b 0.8226 b 
Lower 95% -556.1767 -693.4420 -377.8245 
Upper 95% 187.8070 208.5224 301.3503 
a 95% confidence level= significant linear regression; b 95% 
confidence level= no significant linearity deviation; RA: rosmarinic 
acid; R: correlation coefficient. 
 
Table 2. Intraday and intra-day precision, accuracy and stability 
evaluation of RA standard, rat plasma brain matrices. 
 Level Precision (RSD) Accuracy SE 
 (µg/mL) 
First 
day a 
Second 
day a 
Third 
day a 
Inter-
day 
(%) (%) 
RA  
0.1 3.99 3.99 3.99 3.51 105.53 104.69 
2.0 4.11 1.38 2.68 3.31 97.01 95.58 
   6.0 1.38 0.21 0.33 1.06 101.24 102.37 
10.0 0.72 0.67 0.44 0.77 98.76 99.41 
        
Rat 
plasma 
matrix 
0.1 1.34 2.54 2.18 4.36 108.94 110.99 
2.0 0.82 2.24 2.16 2.40 96.63 95.68 
6.0 1.37 1.03 1.26 1.56 101.34 99.94 
10.0 0.47 0.45 0.39 0.53 99.01 100.25 
        
Rat 
brain 
matrix 
0.1 4.88 1.10 2.44 3.81 91.97 90.44 
2.0 1.80 2.99 1.55 2.90 98.86 96.85 
6.0 1.25 2.38 1.72 2.01 100.38 99.91 
10.0 0.26 0.88 0.55 0.68 99.24 99.21 
a six replicates per day; SE: stability evaluation in 24 hours; RSD= 
relative standard deviation (%); RA: rosmarinic acid. 
 
The results for RA extraction recovery from rat plasma and 
brain recovery are presented in Table 3 and were established 
after preliminary studies. The recovery was higher than 
84.9% and lower than 105.1%, without interference of matrix 
components and with adequate precision RSD lower than 
11.5% for both matrices in accordance with FDA 
recommendations for bioanalytical procedures validation 
[15]. 
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Table 3. RA extraction recovery from rat plasma and brain matrices. 
 Level (µg.mL-1) Recovery (RSD, %) 
Rat plasma 
matrix 
0.1 84.91 (11.5) 
2.0 89.39 (4.9) 
6.0 88.18 (1.3) 
10.0 90.49 (14.9) 
   
Rat brain 
matrix 
0.1 93.72 (5.5) 
2.0 97.82 (11.5) 
6.0 105.07 (2.8) 
10.0 98.55 (3.5) 
RSD: relative standard deviation (%); RA: rosmarinic acid. 
 
 
Conclusions  
 
In present study, a fast and simple UFLC method previously 
reported by our research group was successfully validated for 
determination of RA in rat plasma and brain matrices with 
high sensibility and with high recovery using simple 
extraction processes. This is the first high-throughput liquid 
chromatography method validated for RA determination in 
different complex matrices, allowing its use in further in vivo 
studies. 
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